Delivery Order SPE2DB25D3012-SPE2DB25FXAMF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, a diabetes management medication, under a firm fixed-price contract valued at $4,514.50. The order, placed on September 25, 2025, with an ultimate completion date of September 26, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order from its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Januvia 100 mg tablets (90-count) valued at $4,365.84. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for completion by September 16, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,364.83 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count) on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Januvia 100 mg tablets (90-count) with a ceiling value of $2,105.91. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this award. No set-aside designation was used in this competitive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Januvia 100 mg tablets (90-count units) with a contract value of $7,676.40 and a firm fixed price structure. The award, made on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a non-set-aside, competitively awarded procurement. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Januvia 100 mg tablets (90-count) with a ceiling value of $1,532.11. This competitively awarded, firm fixed-price delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract carries no set-aside designation and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (1,000 count) with a firm fixed price ceiling value of $2,658.67. The order, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a small-value pharmaceutical procurement from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order was not subject to any set-aside designation...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Januvia 100 mg tablets (90-count) valued at $4,732.64, with an ultimate completion date of September 11, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a single pharmaceutical procurement under a larger contract vehicle. The ordering activity and AmerisourceBergen's corporate office, located in Conshohocken, Pennsylvania, serve as the contracting entities and place of...
- The Defense Logistics Agency awarded a delivery order valued at $3,715.55 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count packages) under a firm fixed price contract type. This non-set-aside award was issued on August 21, 2025, with an ultimate completion date of August 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, and the place of performance...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count) with a ceiling value of $2,746.32. This competitively awarded, firm fixed-price delivery order was issued on June 16, 2025, with an ultimate completion date of June 17, 2025. The contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FXAMFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count) under a firm fixed-price contract valued at $25,576.72. The award, issued on September 25, 2025, with an ultimate completion date of September 26, 2025, represents a competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical procurement vendor for military and veteran healthcare systems. This delivery order is executed under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates substantial capability in fulfilling diverse pharmaceutical requirements, with awards consistently structured as competitive, firm fixed-price delivery orders across multiple therapeutic domains including diabetes medications, neurological treatments, and specialty medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.6k | 9/25/25 |